Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
The type IV collagen gene COL4A6 has been implicated in X-linked nonsyndromic hearing loss. Three unrelated hemizygous male probands in three families, including two individuals described here, harbor rare COL4A6 variants c.3269G>C (p.Gly1090Ala) and the splice-site variant c.951+1G>T, inherited from asymptomatic carrier mothers, consistent with X-linked recessive inheritance (PMID:33840813). The missense p.Gly1090Ala remains a variant of uncertain significance, whereas c.951+1G>T results in skipping of exon 15 in an in vitro minigene splicing assay, indicating a deleterious splicing defect (PMID:33840813).
Functional studies in Col4a6 knockout mice reveal normal auditory brainstem responses and cochlear morphology, distinguishing simple loss of gene expression from the human hearing loss phenotype and supporting a dominant-negative mechanism for pathogenic COL4A6 variants (PMID:33848312). Taken together, genetic evidence remains limited with minimal family segregation, but functional data are moderate, implicating COL4A6 in X-linked nonsyndromic hearing loss. Key Take-home: Rare COL4A6 splice and missense variants with demonstrated splicing defects should be considered in the genetic work-up of X-linked sensorineural hearing loss.
Gene–Disease AssociationLimitedThree unrelated hemizygous probands with rare COL4A6 variants segregating in carrier mothers and minimal additional segregation ([PMID:33840813]). Genetic EvidenceLimitedIdentification of one missense and one splice-site variant in three probands across three families with X-linked inheritance and no extensive segregation. Functional EvidenceModerateIn vitro minigene assay shows exon 15 skipping due to c.951+1G>T ([PMID:33840813]); knockout mouse model lacks hearing phenotype, supporting a dominant-negative mechanism ([PMID:33848312]). |